Search

everythinglearnresearchcommunity

for

Search:↓

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Histone demethylases can change gene expression and may be linked to diseases like cancer.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

EGFR helps control how hair grows and forms without needing p53 protein.

The research found that a complex gene network, controlled by microRNAs, is important for hair growth in cashmere goats.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Young donor, early passage stem cells have the highest stemness.

Cashmere and milk goats have different hair growth cycles and gene expressions, which could help improve wool production.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Sebaceous glands age due to genetic and environmental factors, affecting sebum production and composition.

Stress keratins are expressed less in diseased skin and are linked to differentiation, inflammation, and immunity.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Some skin tumors may start from hair follicle stem cells.

Improved understanding of stem cell mechanisms can enhance skin tissue engineering.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

FGF5 spliceosomes inhibit rabbit hair growth by affecting gene expression.

Type XVII collagen helps control skin cell growth and could be a target for anti-aging treatments.

Wharton's jelly stem cells show diverse traits and functions.